MESOMesoblast Limited
$12.27-32% 1Y
$12.27
$11.9552 weeks$20.96
The financials
Mesoblast Limited by the numbers
Mesoblast Limited (MESO) reported revenue of $69M in H2 2026 (quarter ended Jun 30, 2026), up 2641% from the same quarter a year earlier. That came with a gross margin of 87% and net loss of $17M. For the full year FY2026, revenue was $120M (+599% year on year) and net income −$58M.
| Income statement | H2 2026 | H2 2024 | Change |
|---|---|---|---|
| Revenue | $69M | $2.5M | +2641% |
| Gross profit | $60M | n/a | n/a |
| Net income | −$17M | −$55M | n/a |
| Diluted EPS | −$0.01 | −$0.05 | n/a |